C07D 295/185
From aliphatic carboxylic acids
Official title: from aliphatic carboxylic acids
C07D295/185 (From aliphatic carboxylic acids) appears on 1,650 US grants and 1,169 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,650
- Published applications
- 1,169
- Assignees
- 820
- Inventors
- 5,054
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 31 | 0 |
| 1978 | 35 | 0 |
| 1979 | 32 | 0 |
| 1980 | 19 | 0 |
| 1981 | 27 | 0 |
| 1982 | 26 | 0 |
| 1983 | 22 | 0 |
| 1984 | 25 | 0 |
| 1985 | 28 | 0 |
| 1986 | 21 | 0 |
| 1987 | 24 | 0 |
| 1988 | 34 | 0 |
| 1989 | 35 | 0 |
| 1990 | 29 | 0 |
| 1991 | 28 | 0 |
| 1992 | 27 | 0 |
| 1993 | 35 | 0 |
| 1994 | 34 | 0 |
| 1995 | 42 | 0 |
| 1996 | 25 | 0 |
| 1997 | 44 | 0 |
| 1998 | 44 | 0 |
| 1999 | 38 | 0 |
| 2000 | 42 | 0 |
| 2001 | 37 | 12 |
| 2002 | 48 | 48 |
| 2003 | 52 | 86 |
| 2004 | 31 | 84 |
| 2005 | 54 | 89 |
| 2006 | 51 | 65 |
| 2007 | 57 | 77 |
| 2008 | 31 | 64 |
| 2009 | 41 | 54 |
| 2010 | 51 | 60 |
| 2011 | 37 | 38 |
| 2012 | 47 | 43 |
| 2013 | 37 | 30 |
| 2014 | 25 | 40 |
| 2015 | 28 | 38 |
| 2016 | 42 | 42 |
| 2017 | 31 | 34 |
| 2018 | 26 | 35 |
| 2019 | 24 | 28 |
| 2020 | 21 | 28 |
| 2021 | 23 | 36 |
| 2022 | 20 | 34 |
| 2023 | 16 | 33 |
| 2024 | 20 | 28 |
| 2025 | 31 | 21 |
| 2026 | 11 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Bifunctional molecules for targeted protein degradation13 Aug 2026US 2026/0232812 A1
- Traceless reductively cleavable linker molecules for peptide purification6 Aug 2026US 2026/0226099 A1Gyros Protein Technologies AB
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
Most cited
By later US patents
- Photoresist monomers, polymers thereof, and photoresist compositions containing the same470US 6,607,868 B2Hynix Semiconductor Inc. · 2003
- Stilbene derivatives222US 4,326,055 AHoffmann-La Roche Inc. · 1982
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991